Quantbot Technologies LP Trims Stock Position in CME Group Inc. (NASDAQ:CME)

Quantbot Technologies LP reduced its stake in shares of CME Group Inc. (NASDAQ:CME) by 10.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,883 shares of the financial services provider’s stock after selling 2,144 shares during the quarter. Quantbot Technologies LP’s holdings in CME Group were worth $4,167,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Truvestments Capital LLC bought a new stake in shares of CME Group during the 3rd quarter valued at $26,000. Y.D. More Investments Ltd bought a new position in CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. increased its position in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC increased its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CME has been the subject of several recent analyst reports. Piper Sandler upped their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Barclays raised their price target on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Oppenheimer increased their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Finally, The Goldman Sachs Group increased their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $224.47.

Insider Activity at CME Group

In related news, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. The trade was a 8.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 over the last three months. 0.30% of the stock is currently owned by corporate insiders.

CME Group Trading Up 2.2 %

CME opened at $234.39 on Wednesday. The firm has a market cap of $84.47 billion, a price-to-earnings ratio of 24.65, a price-to-earnings-growth ratio of 5.28 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $235.18. The business’s 50 day moving average is $224.18 and its two-hundred day moving average is $211.37. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $2.25 EPS. The company’s revenue was up 18.4% on a year-over-year basis. On average, research analysts predict that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.96%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.